Automated compounding system VARIXIO®

medicalsterilization

Overview
VARIXIO® is an automated microfoam preparation system for sclerotherapy. It standardises the production of consistent, reproducible microfoam and supports preparation at very low sclerosant concentrations when clinically required.

Components

• VARIXIO® Pro Mag — a customised magnetic stirrer with a docking site designed to accommodate VARIXIO® Pod capsules.
• VARIXIO® Pod Air — sterile, single-use capsules enabling preparation of air-based sclerosing foam for varicose veins, haemorrhoids, and venous malformations.
• VARIXIO® Pod Low N2 — sterile, single-use capsules enabling preparation of low-nitrogen physiological gas foam for the same clinical indications.

Key features

• Automated, standardised process that delivers consistent foam quality and repeatability.
• Versatility across sclerosant types and concentrations, including polidocanol (POL) and sodium tetradecyl sulfate (STS) at low doses.
• Safety-oriented options: Pod Air allows foam preparation at very low sclerosant concentrations to help reduce overdose risk; Pod Low N2 provides foam from physiological gas mixtures.
• Capability to prepare larger foam volumes when clinically indicated (useful for some venous malformations and large varicose veins).

Clinical applications

• Treatment of varicose veins
• Haemorrhoids
• Venous malformations

Notes on gases
VARIXIO® Pod Low N2 prepares foam from a physiological gas mixture (typical composition: O2/CO2 with approximately 2–10% N2). Pods are supplied sterile and for single use.

The aim
The aim of VARIXIO® is to provide clinicians with an automated solution for preparing standardised, reproducible microfoam with flexibility across sclerosant concentrations and gas options.

Technical specifications

• Product type: Automated microfoam preparation system for sclerotherapy.
• Main components: VARIXIO® Pro Mag (magnetic stirrer), VARIXIO® Pod Air (sterile single-use capsules), VARIXIO® Pod Low N2 (sterile single-use capsules).
• Indications: varicose veins, haemorrhoids, venous malformations.
• Compatibility: designed for use with POL (polidocanol) and STS (sodium tetradecyl sulfate) at low concentrations.
• Gas options: Air (Pod Air) or low-nitrogen physiological gas mixture (Pod Low N2, O2/CO2 with ~2–10% N2).
• Sterility: Pods are sterile and intended for single use.
• Intended benefits: standardisation and reproducibility of foam preparation; versatility across sclerosant concentrations and gas choices; options to limit sclerosant dose.
• Manufacturer/brand: VB Devices.